SCHEMBL16616580

SCHEMBL16616580

CCO[Si](C)(OC)OC(C)=O

nearest known ligand 0.37

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.37
LMNA P02545 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TSHR P16473 1/20 0.31
MGAM O43451 1/20 0.31
GAA P10253 1/20 0.31
SI P14410 1/20 0.31
MGAM2 Q2M2H8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL839014 0.89 ALDH1A1 (0.42) ALDH1A1LMNAHSD17B10TSHR
SCHEMBL838934 0.89 ALDH1A1 (0.42) ALDH1A1LMNAHSD17B10TSHR
SCHEMBL3910859 0.86 ALDH1A1 (0.40) ALDH1A1LMNAHSD17B10TSHR
SCHEMBL3912974 0.86 ALDH1A1 (0.40) ALDH1A1LMNAHSD17B10TSHR
SCHEMBL728906 0.84 ALDH1A1 (0.39) ALDH1A1LMNAHSD17B10TSHR
SCHEMBL28880785 0.83 ALDH1A1 (0.34) ALDH1A1LMNAHSD17B10
SCHEMBL29067010 0.82 MGAM (0.46) TSHRMGAMGAASIMGAM2
SCHEMBL27550157 0.82 ALDH1A1 (0.41) ALDH1A1TSHR
SCHEMBL838347 0.81 ALDH1A1 (0.42) ALDH1A1TSHRMGAMGAASI
SCHEMBL1289304 0.81 ALDH1A1 (0.42) ALDH1A1TSHRMGAMGAASI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 163 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260118791-A1 TONER CANON KK (JP) 2026-04-30 US disclosed
EP-4086705-B1 TONER CANON KK (JP) 2026-03-25 EP disclosed
EP-4012501-B1 EXTERNAL ADDITIVE FOR TONER, TONER AND IMAGE FORMING APPARATUS CANON KK (JP) 2026-02-11 EP disclosed
EP-3654105-B1 PROCESS CARTRIDGE AND IMAGE FORMING APPARATUS CANON KK (JP) 2026-01-28 EP disclosed
US-12487539-B2 Fine particle, external additive for toners, and toner CANON KABUSHIKI KAISHA (JP) 2025-12-02 US disclosed
US-20250355380-A1 TWO-COMPONENT DEVELOPER CANON KK (JP) 2025-11-20 US disclosed
US-20250334892-A1 FINE POWDER FOR TONER AND TONER CANON KK (JP) 2025-10-30 US disclosed
US-20250334896-A1 EXTERNAL ADDITIVE FOR TONER AND TONER CANON KK (JP) 2025-10-30 US disclosed
US-12443129-B2 Image forming apparatus with simplified developer replenishment structure and that is user-friendly CANON KABUSHIKI KAISHA (JP) 2025-10-14 US disclosed
US-12411428-B2 Toner pack CANON KABUSHIKI KAISHA (JP) 2025-09-09 US disclosed
US-9529289-B2 Method for producing toner particles CANON KABUSHIKI KAISHA (JP) 2016-12-27 US disclosed
US-20160349649-A1 TONER AND METHOD FOR PRODUCING THE SAME CANON KABUSHIKI KAISHA (JP) 2016-12-01 US disclosed
US-20160327882-A1 TONER AND METHOD FOR PRODUCING TONER CANON KABUSHIKI KAISHA (JP) 2016-11-10 US disclosed
US-20150378274-A1 TONER CANON KABUSHIKI KAISHA (JP) 2015-12-31 US disclosed
US-20150378275-A1 METHOD FOR PRODUCING TONER PARTICLES CANON KABUSHIKI KAISHA (JP) 2015-12-31 US disclosed
EP-2860585-A1 Toner Canon Kabushiki Kaisha (JP) 2015-04-15 EP disclosed
EP-2860584-A1 Toner Canon Kabushiki Kaisha (JP) 2015-04-15 EP disclosed
US-20150099220-A1 TONER CANON KABUSHIKI KAISHA (JP) 2015-04-09 US disclosed
US-20150099224-A1 TONER CANON KABUSHIKI KAISHA (JP) 2015-04-09 US disclosed
US-20150099222-A1 TONER CANON KABUSHIKI KAISHA (JP) 2015-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260118791-A1 TONER MSR1, H1-2, TAAR1 ALDH1A1 2569/4885LMNA 1670/4885HSD17B10 2394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.